Literature DB >> 7544860

Neuroleptic sensitivity to risperidone in Lewy body dementia.

I G McKeith, C G Ballard, R W Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7544860     DOI： 10.1016/s0140-6736(95)92307-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

Review 3.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 4.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Dementia with Lewy bodies: clinical features and treatment.

Authors:  S Campbell; S Stephens; C Ballard
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Psychosis Due to Neurologic Conditions.

Authors:  David B. Arciniegas; Jeannie L. Topkoff; Kerri Held; Lauren Frey
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 7.  Neuropsychiatric aspects of dementia with Lewy bodies.

Authors:  N Hirono; J L Cummings
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 8.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders.

Authors:  Prakash S. Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.